1-2 of 2
Al Ali Najla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes (MDS) at the Time of Hypomethylating Agent Failure

Aziz Nazha, MD, Rami S Komrokji, MD, Guillermo Garcia-Manero, MD, John Barnard, Cassie Zimmerman, MA, Al Ali Najla, Gail J. Roboz, MD, David P. Steensma, MD, Amy E. DeZern, MD MHS, Elias Jabbour, MD, Sangmin Lee, MD, Molly D. Greenberg, B.S., Alan F List, MD, Hagop M. Kantarjian, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2014) 124 (21): 3275.
https://doi.org/10.1182/blood.V124.21.3275.3275
Published: 2014
Journal Articles

Outcome Of Patients (pts) With Low and Intermediate-1 Risk Myelodysplastic Syndrome (MDS) After Hypomethylating Agent (HMA) Failure

Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Lianchun Xiao, Al Ali Najla, Asmita Mishra, MD, Eric Padron, MD, Jeffrey E Lancet, MD, Jeffery Bryan, Hillary Prescott, David P. Steensma, MD, Mikkael A. Sekeres, MD, MS, Gail J. Roboz, MD, Alan List, MD, Hagop M Kantarjian, MD, Rami S Komrokji, MD
Journal: Blood
Blood (2013) 122 (21): 388.
https://doi.org/10.1182/blood.V122.21.388.388
Published: 2013